News | November 21, 2025
Alkem launches globally acclaimed De Simone Probiotic in India, expands GI portfolio
The formulation is backed by over 80 clinical trials and 200 scientific publications
The formulation is backed by over 80 clinical trials and 200 scientific publications
This approval is based on positive results from two Phase 3, global, double-blind, placebo-controlled trials
Results from the Phase 2 PHAROS trial potentially establish new benchmark with targeted combination therapies for this patient population
Rifaximin tablets are a rifamycin antibacterial indicated for reducing the risk of overt hepatic encephalopathy
An estimated 50% of patients with ER+, HER2– metastatic breast cancer will develop an ESR1 mutation during or after exposure to an aromatase inhibitor
Ascletis announces ultra-long-acting subcutaneous depot maintenance formulation of small molecule GLP-1R agonist ASC30 with 75-Day observed half-life in participants with obesity
Octreotide is synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid phase synthesis
Data demonstrate the importance of protecting against serious respiratory infections caused by respiratory syncytial virus, human metapneumovirus and COVID-19
Launches Opentop 40, Opentop D, Opentop L, Opentop Dsr and Cefix 200 which are available for sale
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
Subscribe To Our Newsletter & Stay Updated
